• Je něco špatně v tomto záznamu ?

Clinical features and blood iron metabolism markers in children with beta-propeller protein associated neurodegeneration

A. Belohlavkova, K. Sterbova, C. Betzler, S. Burkhard, A. Panzer, M. Wolff, P. Lassuthova, M. Vlckova, M. Kyncl, B. Benova, A. Jahodova, M. Kudr, M. Goerg, P. Dusek, P. Seeman, G. Kluger, P. Krsek

. 2020 ; 28 (-) : 81-88. [pub] 20200804

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012192

BACKGROUND: Neurodegeneration with brain iron accumulation constitutes a group of rare progressive movement disorders sharing intellectual disability and neuroimaging findings as common denominators. Beta-propeller protein-associated neurodegeneration (BPAN) represents approximately 7% of the cases, and its first signs are typically epilepsy and developmental delay. We aimed to describe in detail the phenotype of BPAN with a special focus on iron metabolism. MATERIAL AND METHODS: We present a cohort of paediatric patients with pathogenic variants of WD-Repeat Domain 45 gene (WDR45). The diagnosis was established by targeted panel sequencing of genes associated with epileptic encephalopathies (n = 9) or by Sanger sequencing of WDR45 (n = 1). Data on clinical characteristics, molecular-genetic findings and other performed investigations were gathered from all participating centres. Markers of iron metabolism were analysed in 6 patients. RESULTS: Ten children (3 males, 7 females, median age 8.4 years) from five centres (Prague, Berlin, Vogtareuth, Tubingen and Cologne) were enrolled in the study. All patients manifested first symptoms (e.g. epilepsy, developmental delay) between 2 and 31 months (median 16 months). Seven patients were seizure-free (6 on antiepileptic medication, one drug-free) at the time of data collection. Neurological findings were non-specific with deep tendon hyperreflexia (n = 4) and orofacial dystonia (n = 3) being the most common. Soluble transferrin receptor/log ferritin ratio was elevated in 5/6 examined subjects; other parameters of iron metabolism were normal. CONCLUSION: Severity of epilepsy often gradually decreases in BPAN patients. Elevation of soluble transferrin receptor/log ferritin ratio could be another biochemical marker of the disease and should be explored by further studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012192
003      
CZ-PrNML
005      
20210507102156.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejpn.2020.07.010 $2 doi
035    __
$a (PubMed)32811771
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Belohlavkova, Anezka $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
245    10
$a Clinical features and blood iron metabolism markers in children with beta-propeller protein associated neurodegeneration / $c A. Belohlavkova, K. Sterbova, C. Betzler, S. Burkhard, A. Panzer, M. Wolff, P. Lassuthova, M. Vlckova, M. Kyncl, B. Benova, A. Jahodova, M. Kudr, M. Goerg, P. Dusek, P. Seeman, G. Kluger, P. Krsek
520    9_
$a BACKGROUND: Neurodegeneration with brain iron accumulation constitutes a group of rare progressive movement disorders sharing intellectual disability and neuroimaging findings as common denominators. Beta-propeller protein-associated neurodegeneration (BPAN) represents approximately 7% of the cases, and its first signs are typically epilepsy and developmental delay. We aimed to describe in detail the phenotype of BPAN with a special focus on iron metabolism. MATERIAL AND METHODS: We present a cohort of paediatric patients with pathogenic variants of WD-Repeat Domain 45 gene (WDR45). The diagnosis was established by targeted panel sequencing of genes associated with epileptic encephalopathies (n = 9) or by Sanger sequencing of WDR45 (n = 1). Data on clinical characteristics, molecular-genetic findings and other performed investigations were gathered from all participating centres. Markers of iron metabolism were analysed in 6 patients. RESULTS: Ten children (3 males, 7 females, median age 8.4 years) from five centres (Prague, Berlin, Vogtareuth, Tubingen and Cologne) were enrolled in the study. All patients manifested first symptoms (e.g. epilepsy, developmental delay) between 2 and 31 months (median 16 months). Seven patients were seizure-free (6 on antiepileptic medication, one drug-free) at the time of data collection. Neurological findings were non-specific with deep tendon hyperreflexia (n = 4) and orofacial dystonia (n = 3) being the most common. Soluble transferrin receptor/log ferritin ratio was elevated in 5/6 examined subjects; other parameters of iron metabolism were normal. CONCLUSION: Severity of epilepsy often gradually decreases in BPAN patients. Elevation of soluble transferrin receptor/log ferritin ratio could be another biochemical marker of the disease and should be explored by further studies.
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a transportní proteiny $x genetika $7 D002352
650    _2
$a dítě $7 D002648
650    _2
$a epilepsie $x krev $x genetika $x metabolismus $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mentální retardace $x krev $x genetika $x metabolismus $7 D008607
650    _2
$a železo $x krev $7 D007501
650    _2
$a poruchy metabolismu železa $x krev $x genetika $x metabolismus $7 D019189
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pohybové poruchy $x krev $x genetika $x metabolismus $7 D009069
650    _2
$a neurodegenerativní nemoci $x krev $x genetika $x metabolismus $7 D019636
650    _2
$a fenotyp $7 D010641
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sterbova, Katalin $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Betzler, Cornelia $u Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik, Vogtareuth, Germany; Research Institute for Rehabilitation, Transition and Palliation, Paracelsus Medical University Salzburg, Austria
700    1_
$a Burkhard, Stuve $u Children's Hospital Amsterdamer Straße, Kliniken der Stadt Köln, Cologne, Germany
700    1_
$a Panzer, Axel $u Epilepsy Center, Paediatric Neurology, DRK Kliniken Berlin-Westend, Berlin, Germany
700    1_
$a Wolff, Markus $u Department of Neuropediatrics, University Children's Hospital, Tübingen, Germany
700    1_
$a Lassuthova, Petra $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Vlckova, Marketa $u Department of Biology and Medical Genetics, Charles University, Second Faculty of Medicine and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Kyncl, Martin $u Department of Radiology, Charles University, Second Faculty of Medicine and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Benova, Barbora $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Jahodova, Alena $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Kudr, Martin $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Goerg, Maria $u Department of Neuropaediatrics, Centrum for Social Paediatry, St. Mary´s Children Hospital, Landshut, Germany
700    1_
$a Dusek, Petr $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Seeman, Pavel $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic
700    1_
$a Kluger, Gerhard $u Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik, Vogtareuth, Germany; Research Institute for Rehabilitation, Transition and Palliation, Paracelsus Medical University Salzburg, Austria
700    1_
$a Krsek, Pavel $u Department of Paediatric Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Member of the ERN EpiCARE Motol Epilepsy Center, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: pavel.krsek@fnmotol.cz
773    0_
$w MED00149836 $t European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society $x 1532-2130 $g Roč. 28, č. - (2020), s. 81-88
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32811771 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102156 $b ABA008
999    __
$a ok $b bmc $g 1650546 $s 1132571
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 28 $c - $d 81-88 $e 20200804 $i 1532-2130 $m European journal of paediatric neurology $n Eur J Paediatr Neurol $x MED00149836
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace